NexImmune, Inc.

NEXI

NexImmune, Inc.

NEXI

Insider Sentiment (TTM):

Last Purchase:2024-06-11Last Sale:2023-11-22Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2024-09-30Institutional Shares Owned:10,804Shares Outstanding:1,380,395Institutional Ownership Pct.:0.78%

Earnings Market Reaction:

Filing Date:2024-08-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	2	4	3	9	16	22	35	46	41	25	30	37
Restricted Cash Current	0	0	0	0	0	0	0	0	0	0	0	0
Marketable Securities Current	-	-	-	-	-	-	0	0	12	41	51	56
Assets Of Disposal Group Including Discontinued Op…	-	-	1	-	-	-	0	-	-	-	-	-
Assets Held For Sale Long Lived Fair Value Disclos…	0	1	-	-	-	0	-	-	-	-	-	-
Prepaid Expense And Other Assets Current	1	1	1	1	2	3	3	6	6	7	4	5
Assets Current	3	6	5	10	19	25	37	52	60	72	86	99
Property Plant And Equipment Net	1	1	1	4	4	4	4	5	5	4	4	4
Operating Lease Right Of Use Asset	0	0	0	1	1	1	1	1	1	1	0	-
Other Assets Noncurrent	2	2	2	0	0	0	0	0	0	1	0	2
Assets	6	9	9	15	23	31	43	58	66	78	91	105
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	1	1	1	1	1	2	1	2	2	1	4
Accrued Liabilities Current	3	4	4	5	5	6	7	8	7	4	6	4
Operating Lease Liability Current	0	0	0	1	1	1	1	1	1	1	0	-
Liabilities Current	5	5	5	6	6	7	10	9	9	7	7	7
Derivative Liabilities Current	-	-	-	-	-	-	-	-	-	-	0	0
Operating Lease Liability Noncurrent	-	-	0	0	0	0	0	1	1	1	0	-
Other Liabilities Current	-	-	-	-	-	-	-	-	-	-	0	0
Deferred Rent Credit Noncurrent	-	-	-	-	-	-	0	0	0	0	0	0
Due To Related Parties Current	-	-	-	-	-	-	-	-	-	-	0	0
Derivative Liabilities Noncurrent	0	1	-	-	-	-	-	-	-	-	-	-
Liabilities	5	6	5	6	6	7	11	10	10	8	7	7
Convertible Notes Payable Current	-	-	-	-	-	-	-	-	-	-	0	0
Temporary Equity Carrying Amount Attributable To P…	0	0	-	-	0	0	-	-	-	-	-	-
Stockholders Equity
Preferred Stock Value	0	-	-	-	-	-	-	-	-	-	0	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	229	228	226	225	224	223	223	221	214	213	211	209
Other Liabilities Noncurrent	-	-	-	-	-	-	-	-	-	-	0	0
Retained Earnings Accumulated Deficit	-228	-226	-223	-217	-207	-200	-190	-173	-159	-143	-128	-112
Stockholders Equity	1	3	4	8	17	24	32	48	56	70	84	97
Accumulated Other Comprehensive Income Loss Net Of…	-	-	-	-	-	-	0	0	-0	-0	0	0
Liabilities And Stockholders Equity	6	9	9	15	23	31	43	58	66	78	91	105
Redeemable Noncontrolling Interest Equity Preferre…	-	-	-	-	-	-	-	-	-	-	0	0
Preferred Stock Par Or Stated Value Per Share	0	-	-	-	-	-	-	-	-	-	0	-
Preferred Stock Shares Authorized	0	-	-	-	-	-	-	-	-	-	10	-
Preferred Stock Shares Issued	0	-	-	-	-	-	-	-	-	-	0	-
Preferred Stock Shares Outstanding	0	-	-	-	-	-	-	-	-	-	0	-
Common Stock Number Of Sh…
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	250	250	250	250	250	250	250	250	250	250	250	250
Common Stock Shares Issued	1	1	1	1	1	1	1	1	1	1	1	1
Shares Outstanding	1	1	1	1	1	1	1	1	1	1	1	1
Series A Redeemable Convertible Preferred Stock	-	-	-	-	-	-	-	-	-	-	0	0
Series A Two Redeemable Convertible Preferred Stoc…	-	-	-	-	-	-	-	-	-	-	0	0
Series A Three Redeemable Convertible Preferred St…	-	-	-	-	-	-	-	-	-	-	0	0
Temporary Equity
Preferred Stock Number Of…
Subsequent Event	-	-	-	1	-	-	-	-	-	-	-	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2024	-8.10%	-7.17%	-63.80%	-59.82%	-77.68%	-80.57%	-	-	-	-	-	-
2023	12.46%	1.39%	-1.82%	-21.38%	-21.42%	-38.00%	48.39%	149.19%	408.06%	3.75%	-13.54%	-31.70%
2022	6.93%	-14.85%	-43.07%	-19.84%	-47.27%	-55.54%	-26.04%	-32.79%	-11.89%	-0.97%	9.21%	-13.13%
2021	-	-	-	34.79%	43.41%	7.87%	-41.04%	-57.00%	-71.92%	93.91%	-8.26%	-15.22%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
Liquidity Ratios
Current Ratio	0.66	1.30	1.06	1.66	2.95	3.74	3.62	5.54	6.54	10.14	11.96	13.28
Quick Ratio	0.55	1.18	0.92	1.46	2.61	3.30	3.36	4.89	5.84	9.18	11.35	12.55
Working Capital	-1.61M	1.41M	316.73K	4.12M	12.23M	18.62M	27.04M	42.61M	50.48M	64.81M	79.06M	91.29M
Leverage & Debt
Debt to Equity	7.10	2.20	1.45	0.76	0.38	0.30	0.33	0.21	0.18	0.11	0.09	0.08
Interest Coverage TTM	-	-	-	-	-	-	-	-	-56,059.72	-48,251.12	-58.82	-
Debt Ratio	0.84	0.67	0.59	0.43	0.28	0.23	0.25	0.17	0.15	0.10	0.08	0.07
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-
Per Share Metrics
Diluted EPS TTM	-14.94	-20.68	-30.82	-41.87	-46.74	-54.69	-64.95	-62.23	-66.33	-62.40	-63.04	-
Free Cash Flow Per Share TTM	-12.75	-17.25	-30.00	-35.31	-40.40	-45.97	-54.50	-54.33	-55.09	-58.26	-59.61	-
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-
Growth Metrics
Net Income Growth (1Y)	-57.71%	-54.68%	-48.25%	-27.78%	-19.65%	0.08%	22.80%	-	-	-	-	-
EPS Growth (1Y)	-68.04%	-62.19%	-52.55%	-32.71%	-29.53%	-12.36%	3.03%	-	-	-	-	-
Valuation Metrics
P/E TTM	-0.18	-0.27	-0.07	-0.13	-0.15	-0.17	-0.09	-0.22	-0.61	-1.69	-1.83	-
P/B TTM	5.47	2.56	0.66	0.67	0.43	0.42	0.18	0.28	0.66	1.37	1.11	3.53
Market Cap	3.81M	7.02M	2.33M	5.50M	7.35M	9.91M	5.85M	13.54M	36.82M	96.14M	93.06M	342.97M
Enterprise Value	1.37M	2.54M	-892.63K	-3.56M	-8.99M	-12.46M	-28.85M	-32.43M	-3.93M	71.57M	62.66M	305.65M
Calculated Values
Free Cash Flow TTM	-17.61M	-21.57M	-31.48M	-37.00M	-42.14M	-47.95M	-52.45M	-53.05M	-50.40M	-53.22M	-48.14M	-
Net Debt	-2.44M	-4.47M	-3.22M	-9.06M	-16.34M	-22.37M	-34.70M	-45.97M	-40.75M	-24.57M	-30.39M	-37.32M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-06-11Purchase

Owner: Jones, Kristi

Title: President and CEO

Shares: 1

Price/Share: $0.01

Value: $0.01

Shares Owned: 1

Relationship: Director,Officer

Ownership: Direct

2023-11-22Sale

Owner: Roemer, Alan S.

Title: -

Shares: 3,992

Price/Share: $1.94

Value: $7,744.48

Shares Owned: -

Relationship: Director

Ownership: Direct

2023-03-30Purchase

Owner: Barer, Sol J

Title: -

Shares: 400,000

Price/Share: $0.41

Value: $164,000.00

Shares Owned: 2,217,814

Relationship: Director

Ownership: Direct

2022-11-17Purchase

Owner: Barer, Sol J

Title: -

Shares: 75,000

Price/Share: $0.48

Value: $36,000.00

Shares Owned: 1,817,814

Relationship: Director

Ownership: Direct

2022-06-07Purchase

Owner: Verstandig, Grant

Title: -

Shares: 26,876

Price/Share: $2.28

Value: $61,277.28

Shares Owned: 1,105,495

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2024-06-11	Jones, Kristi	Director,Officer	President and CEO	Direct	Purchase	1	0.01	$0.01	1	4
2023-11-22	Roemer, Alan S.	Director	-	Direct	Sale	3,992	1.94	$7,744.48	0	4
2023-03-30	Barer, Sol J	Director	-	Direct	Purchase	400,000	0.41	$164,000.00	2,217,814	4
2022-11-17	Barer, Sol J	Director	-	Direct	Purchase	75,000	0.48	$36,000.00	1,817,814	4
2022-06-07	Verstandig, Grant	Director	-	Direct	Purchase	26,876	2.28	$61,277.28	1,105,495	4
2022-06-02	Barer, Sol J	Director	-	Direct	Purchase	20,720	2.22	$45,998.40	1,617,814	4
2022-06-02	Verstandig, Grant	Director	-	Direct	Purchase	47,900	2.23	$106,817.00	1,038,619	4
2022-03-29	Jones, Kristi	Director,Officer	President and CEO	Direct	Purchase	10,000	3.74	$37,400.00	73,078	4
2022-03-28	Verstandig, Grant	Director	-	Direct	Purchase	18,983	3.76	$71,376.08	905,495	4
2022-03-23	Barer, Sol J	Director	-	Direct	Purchase	10,000	2.67	$26,700.00	1,517,814	4
2022-03-22	Barer, Sol J	Director	-	Direct	Purchase	30,000	2.41	$72,300.00	1,507,814	4
2022-03-21	Barer, Sol J	Director	-	Direct	Purchase	30,000	2.14	$64,200.00	1,477,814	4
2022-03-18	Barer, Sol J	Director	-	Direct	Purchase	30,000	2.11	$63,300.00	1,447,814	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2024-09-30

0.78%

Inst. Shares: 10,804

Shares Outstanding: 1,380,395

2024-06-30

10.72%

Inst. Shares: 148,044

Shares Outstanding: 1,380,395

2024-03-31

12.23%

Inst. Shares: 152,986

Shares Outstanding: 1,250,498

2023-12-31

9.86%

Inst. Shares: 103,458

Shares Outstanding: 1,049,468

2023-09-30

Inst. Shares: 4,329,767

Shares Outstanding: 1,047,871

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2024-09-30	10,804	1,380,395	0.78%
2024-06-30	148,044	1,380,395	10.72%
2024-03-31	152,986	1,250,498	12.23%
2023-12-31	103,458	1,049,468	9.86%
2023-09-30	4,329,767	1,047,871	-
2023-06-30	4,355,060	1,043,138	-
2023-03-31	5,463,444	1,043,138	-
2022-12-31	3,853,079	962,364	-
2022-09-30	7,835,237	976,413	-
2022-06-30	8,298,272	914,855	-
2022-03-31	9,541,992	913,471	-
2021-12-31	10,207,364	807,445	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

NexImmune, Inc. (NEXI) — SEC Financial Statements & Analysis

NexImmune, Inc. (NEXI) is a pharmaceutical preparations company, incorporated in DE. NexImmune, Inc. trades on OTC as: NEXI. Based on its latest SEC filing (Form 10-Q, period ending 2024-06-30), NexImmune, Inc. reported a Debt-to-Equity ratio of 7.10x, a Price-to-Book (P/B) ratio of 5.47x (TTM), at a market cap of $3.81M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 7.10x
P/B TTM: 5.47x
Market Cap: $3.81M

Data as of 2024-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is NexImmune, Inc. in?

NexImmune, Inc. (NEXI) operates in the Pharmaceutical Preparations industry.

What is NEXI's market cap?

NexImmune, Inc. (NEXI) has a market capitalization of $3.81M as of 2024-06-30.

What exchange does NEXI trade on?

NexImmune, Inc. (NEXI) trades on the OTC.

Where is NexImmune, Inc. incorporated?

NexImmune, Inc. is incorporated in DE.

NexImmune, Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

NexImmune, Inc. (NEXI) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

NexImmune, Inc. (NEXI) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.